Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studiesWilma Barcellini, Alberto Zanella, Francesco Zaja et al.|Blood|2012Cited by 144
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long‐term responseMiriam Marangon, Francesco Zaja, Nicola Vianelli et al.|European Journal Of Haematology|2016Cited by 90
Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myelomaMarco Ladetto, Benedetto Bruno, Simone Ferrero et al.|Leukemia|2015Cited by 36
Allogeneic Hematopoietic Cell Transplantation from Unrelated Donors in Multiple Myeloma: Study from the Italian Bone Marrow Donor RegistryRoberto Passera, Benedetto Bruno, Simona Pollichieni et al.|Biology of Blood and Marrow Transplantation|2013Cited by 21
Prospective Molecular Monitoring of Minimal Residual Disease after Non-Myeloablative Allografting in Newly Diagnosed Multiple MyelomaBenedetto Bruno, Marco Ladetto, Simone Ferrero et al.|Blood|2014Cited by 5